<DOC>
	<DOCNO>NCT02406118</DOCNO>
	<brief_summary>The purpose study evaluation safety efficacy transanal total mesorectal excision .</brief_summary>
	<brief_title>Phase II Clinical Trial Evaluation Efficacy Transanal TME</brief_title>
	<detailed_description>Subjects rectal cancer remove use technique combine surgery anus standard laparoscopy . Transanal visualization use endoscopy . At end procedure , rectum remove though anus ileostomy formation site , bowel re-connected anus , temporary diverting stoma create , standard care follow surgery type cancer .</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>1. age : 2080 year 2. biopsyproven adenocarcinoma rectum 3. clinical staging ( c yc ) : T03 , N02 , M0 4 . Rectal cancer locate 312 cm anal verge 5 . ECOG performance status : 2 less 6 . BMI : le 30 1 . Synchronous colon cancer malignancy 2 . Obstructing rectal cancer 3 . Pregnant breastfeed 4 . Receiving study agent 5 . Fecal incontinence 6 . History prior colorectal cancer inflammatory bowel disease 7 . Tumor size : 7cm long diameter 8 . CRM : mesorectal fascia involvement le 1 mm MRI</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>transanal TME quality</keyword>
	<keyword>CRM</keyword>
</DOC>